UPDATE : Friday, September 21, 2018
Local drug makers strive to conquer neurological diseases by So Jae-hyeon 2018-07-09 12:09
Platform technologies key to developing new drugs by So Jae-hyeon 2018-07-03 16:12
SillaJen to develop biomarker for JX-970 by So Jae-hyeon 2018-07-03 14:19
Eisai’s Aricept dominates dementia treatment market by So Jae-hyeon 2018-06-29 15:24
Botulinum toxin makers compete to expand indications by So Jae-hyeon 2018-06-29 14:07
GC, SK Chemical vaccines win export deals by So Jae-hyeon 2018-06-25 12:13
Why was Il-yang out from innovative pharmaceutical firms list? by So Jae-hyeon 2018-06-20 17:13
Companies enter pharma biz through equity investment, acquisition by So Jae-hyeon 2018-06-18 16:13
Samsung Bioepis to promote rheumatism treatments in Europe by So Jae-hyeon 2018-06-14 14:59
What if South Korea supplies vaccines for North? by So Jae-hyeon 2018-06-12 15:36
Obesity drugs marked poor sales in Q1 by So Jae-hyeon 2018-06-12 15:32
60 general hospitals use genetic therapy Invossa by So Jae-hyeon 2018-06-11 15:12
Multinationals dominated drug sales in Q1 -- again by So Jae-hyeon 2018-06-08 16:22
Viagra, Cialis overcome by generic copies by So Jae-hyeon 2018-06-05 10:55
US law expected to benefit Korean drugmakers by So Jae-hyeon 2018-06-04 16:02
Eisai picks Chong Kun Dang as dementia drug sales partner by So Jae-hyeon 2018-06-04 14:10
Biosimilars quickly catch up with originals in Korea by So Jae-hyeon 2018-06-01 15:37
Pfizer Korea ignores reporters’ questions by So Jae-hyeon 2018-06-01 15:18
Korea United Pharm wages war on Chinese fake capsules by So Jae-hyeon 2018-06-01 12:05
OCI enters pharma sector via joint venture with Bukwang by So Jae-hyeon 2018-05-31 15:38
Back to Top